Global Implantable Insulin Pump Market to Reach $6.44 Billion by 2030: Allied Market Research

As per the report published by Allied Market Research, the global Implantable Insulin Pump Market was pegged at $2.67 billion in 2020, and is estimated to reach $6.44 billion by 2030, growing at a CAGR of 9.1% from 2021 to 2030.

Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/3419

Rise in prevalence of diabetes across the globe, surge in government expenditure on healthcare, and sedentary and unhealthy lifestyle drive the global implantable insulin pump market. However, stringent government regulations hinder the market growth. On the contrary, high market growth potential in emerging markets would open new opportunities for the market players in the future.

The report segments the global implantable insulin pump market on the basis of type, disease, end user, and region.

Based on type, the open-loop insulin pump segment held the lion's share in 2020, accounting for nearly 88% of the market. Moreover, the segment is projected to manifest the highest CAGR of 9.3% from 2021 to 2030. The report analyzes the closed-loop insulin pump segment.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/3419

On the basis of end user, the hospitals segment held the largest share in 2020, contributing to nearly two-thirds of the market. However, the home care segment is projected to register the highest CAGR of 9.6% during the forecast period.

The global implantable insulin pump market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America dominated in 2020 in terms of revenue, accounting for nearly two-fifths of the market. However, the market across Asia-Pacific is expected to portray the highest CAGR of 11.5% during the forecast period.

The global implantable insulin pump market report includes an in-depth analysis of the prime market players such as CVS Health (Aetna Inc.), Apex Medical, Diamesco Co., Ltd, Diabeloop, Insulet Corporation, F. Hoffmann La Roche Ltd, Medtronic Plc, Johnson & Johnson, SOOIL Developments Co. Ltd, and Tandem Diabetes Care.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll-Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.